Health Care

Biologics center gets 44.5M grant from NIMH

RUCDR Infinite Biologics has received a $44.5 million grant from the National Institute of Mental Health, which enables federally funded scientists to use the Rutgers-based genetic research facility as their primary resource for studying genomic research and mental disorders.

Read More »

Soligenix closes 7.1M public offering

Princeton-based pharmaceutical company Soligenix announced today the closing of its $7.1 million public offering. The closing included 6. 7 million shares of common stock as well as five-year warrants to purchase up to 5.08 million shares of common.

Read More »